EFTA00266821.pdf

CON')QR 719RCETI i\C% 1.) -1 n SIC DF.-1\;-1 BE-. ‘,16O\-4 aoac) ,>2un CDO'S F)rrert cck . MC11C)atan C l Lt VCACcAn-i ty ,-ti boricI t ip - AV N.tc.,1 tivf:,-CP)u_ED CA5 C_GA-Aec;TeeN CeNc.6 qv ad -r14/-141 06/ gc. Sea, 6' 1 Cc S 4 C osr)co/ • -Tcw-Er-itr, ineoticc,kkl cr15.kr,e.ere -ok - IO Ic 5xfctftc cc,nce,„- Ccus -io t‘c;1...”4, 1 -1(.1 eTei vlork-,NcA‘ fe SoorC e 5 f-/ 11,c. j onciee ,c \c,„:. ev.--1,(01/4c-le8 EFTA00266821 Under an NDA JC INNOVATIONS 2020 Signed NDA and review by a GP, Kadina +on corn lip keA to r1 O-C pVccetbre qr OO1 W11,15- k1A- I<C1(pep4R3•4 1:.), apfeCACO( C'etirsCev- c_e0.3 anC) cror CO ke4 ion d~ oc (is . OO\ mint SA-Gtk akvcc-AL) COWL e .. rna.55 , Re A tsc,(:, FATHERS 1411•W 1.7•Nkr11-C- Th(171 AZACC Ni CT I I•1STFILL (..) LIN) C C.VIPOTER UN-m- Q019 Go4RWEI\Yr FOtIceb Pi-‘D sreoin<,-T-A2-, fkieNcoc_ itookmRy - 5A . v202C. EFTA00266822  • -tom ye t Soc) 5cte 1S-i-s and clytyarin5 kk C"‘"C)x it-13 *Or 4413erd: P ISOL) EC-T Of 3C INNO•lefric-ANS 5 Reel151-ER eD gosi IN\ESS c:20 I 9 IN43-ret-Lco oN cnor-1Purr CR QC% 9 • It.v5Aes::\ 1-LmOn Cell PdrnIntaircrttn RcTC 1,,;(41-) kit Obs_c-1 tale Qf ciirec-k 1.1 -icorcy-ktr5 concer cell niCISr-LS wt-khx,-, AN-e. \occ) , in)141,-) 41-e. po-tech O( CC 0011/44:InCennerrt 40 aziok SS 0 -1-irier tyr_ch c 01 I SS Ce..5 • EFTA00266823 Dr Richard Daehn Kadina Medical Associates B.Med.Sci; BMBS (Flinders); FRACOP PO Box 371 Provider Number: 461797CA Unit 77-79 Port Road Email: Kadina SA 5554 Phone: Fax: 26 May 2020 Dear Jacqueline, Thank you for trusting me to review your scientific and medical research projects. I have read your proposals, and would suggest the following: 1) aim to focus on 1 main area of research only. By doing this, you can direct all your energy and ideas into it, rather than diluting it amongst multiple. You are more likely to make progress if you focus on the one idea. 2) refine what it is you are asking. In other words, rather than presenting a variety of thoughts and ideas, seek to refine and combine them into a unifying hypothesis. 3) In your mental illness proposal, you are challenging current understanding of how the hypothalamus, pituitary and subsequent glands work. Doing this is going to be controversial and not well received in the scientific community. If you chose to go down this path, I would strongly suggest you first undertake further research into this field and uncover whether anyone previously has undertaken research in this field. Research is challenging and time consuming. There is no point re-inventing the wheel. If someone has already done some research in this field, please look into this, to avoid replicating it, or pursuing already demonstrated dead-ends. 4) The strength of any scientific and medical research projects is increased if you cite references and sources to support your ideas. At present, you have not done this, thus it can easily be dismissed as your "opinion". I hope this helps. I wish you good fortune in your scientific and medical research projects. Yours sincerely, r -A1 Dr Richard Daehn In Association With: Dr I i mot hy Wood. Dr Graham Morris. Dr Michael Gregg& Dr Fazil Juriejo. EFTA00266824 Dr Richard Daehn JC INNOVATIONS Kadina Medical Centre Australia Kadina 5554 CONFIDENTIAL 17th April 2020 Dear Dr Daehn, I would like to thank you for agreeing to reviewing the Scientific and Medical Research Projects that I have developed, as discussed during our phone contact, 17th April 2020. I do understand that your time is restricted at this present time due to the demand of the Coronavirus as you stated so am not stipulating a time frame on your review, so please do so at your leisure and convenience. I have included the Scientific and Medical Research Projects for your review and am seeking your input, involvement, support or direction in finding a leading Medical Scientist in Australia to lead the projects to development, completion and success. I would appreciate any information, support or direction that you could provide regarding this matter. The projects are developed as part of my registered business JC INNOVATIONS, Australia, therefore Strict Confidentiality is essential and a signed NDA will be required before the information or documents can be shared with a third party. I can be contacted via either my email service or phone contact or which ever one is convenient or preferable for you. Please contact me at a time that is convenient to you. Your involvement would be much appreciated. I appreciate your time and consideration regarding this matter. Kind Regards Jacqueline Pearce Direct • Email: PH: EFTA00266825 CONFIDENTIAL- JC INNOVATIONS - 2019 EXECUTIVE SUMMARY - MEDICAL RESEARCH PROJECT TARGETED HUMAN CELL ADMINISTRATION PROJECT Targeting of Cancer Cell Mass within the human body Concept Mode of Administration: Direct injection of a bioactive agent into the specific target cancer cell masses. Targeting Strategy: Engineered delivery system to specific cancer cell types to avoid damage to surrounding tissues, leading to targeted necrosis (death) of cancer tumours. Depending on the location and size of the 'liquefied' cancer tissues, these will either be naturally expelled by the body after action of the bioactive agent or removed surgically upon completion of tissue necrosis. Bioactive agents Multiple spider species, e.g. spiders of the genus Loxosceles such as the brown recluse spider, produce necrotic venoms that contain enzymes that specifically degrade cell membrane components, as well as peptides and other bioactives that interfere with vital cellular processes, such as mitochondrial vitality. Such compounds have the potential to be exploited for the development of novel approaches that lead to cancer cell lysis. To maximise the efficiency of such molecules and avoid or limit side effects on normal tissues, there is a need to specifically target the cancer cells. It is proposed to address this problem by engineering specific delivery systems that would administer the selected bioactive agents from the spider venoms directly into the tumours, leading to their destruction in situ. By this mechanism, the cells from a cancer mass would die, which would prevent their spread in other parts of the body and constrain the risk of metastasis. A targeted in situ administration of the bioactive agents would maximise efficiency while limiting any adverse effects. Cell Physiology— Tissue Necrosis Membrane integrity is lost when the cell undergoes necrosis in which the cells die rapidly as a result of lysis. This in turn causes a decrease in cell viability, which stops the cells from actively growing and dividing. Also as a result the cells can activate a genetic program of controlled death of the cell ( Apoptosis ). Typically as a result of necrosis the cells exhibit rapid swelling, lose membrane integrity, metabolism shut down and release their contents into their surroundings. Rapid necrosis of the cells in vitro will result in the loss of sufficient time or energy to activate apoptotic machinery and will not present apoptotic markers. The characterized definition of Apoptotic is defined by cytoplasmic and molecular events. Changes include a refractive index of the cell, cytoplasmic shrinkage, nuclear condensation and cleavage of DNA into regularly sized fragments. Shut down of the cells metabolism, membrane integrity and lyse will then occur. EFTA00266826  CÆ)NE-tOemifit... - 4/"dri . Ni.,1 - it (c...)citaolci .71F W Seov,'Laezt4 D‘sccvex,i fro3eck . icakv-)e- - Seckv-bed a-A4ractICX) process - encdneeA-ed 40 be In medical cict-l-tertl-5 r{t ir rredt col inncen CdnnIn‘k-ct-Ficr) - )n-fr-cNionaGs - inxc-4-ton -SVC bOcil , noneno 'bodily _prelicÆ ord enstneerec.) no-I 46 -We hody. 4 ~col e\ei\\‘7-cx\ ken GcLA.Nrcel Crkroc -k\cAr) - cezxwegsc r ) ‘(-A-0 cicoinf;d i -r- - I-he V3 00 1`l SvJokOS eft - sAer, \\ 7e-x; kan e.goirryr.n4 cr- 0( oflrev po-kerrl-S .t~ ~lice) pvocedure 4 k-c..4 re9ohres :S-b--Nizo-her> . -4 c ‘ frx‘C c_c_oVers tor) x(40 T .1 - sAcbca --ze d‘vect raf3"-Rv-Nwp-kroak- \cn 1--kornan Celt prdinntet- ?cor k trecred ero-kee-1 sorircu-,dv-r_,\ cek\S SriatN.)eeci voc--;kan of ol cji not - cor.rriNeico GuF_R : ex=xe.C 4 (c\ --Srre \C- ope\ keSiOnsicleAtICer) rer*S - ac.CLI c{eavnS --FtiCA0‘ Cce-AvYNS 5k \ ir) products - on-H v\winkle.. astenn3 (-4,g1,4.43 t 1\)G-1oral erkterk scAxce - c-5,--I(c)c-iton - -$0,‘Aeot ord 3e.,UNK.‘sh - combino-i-‘01-) rnotytne., bkolesi . 961 eVencA - kft‘c\S - ColleTn - Uv evo-lect-tml_psin - on--\\ - ox.‘dcw-)A-S Spe-S-S -kC-S - S an CCA‘ n ?(CdLiCkl t Or\ / e. -ko 12 c_ornk ‘irtad kiN)141n 0 \ based prOolOCIS -4-trerk Ce\e.,\ ( j(CY\ .\ -he s\c‘tr) rests-hec.\ Obsortrbor) 5 neceSScv on-1-s -4e sroWpt erleCir)01 sak - fresecbrek needea In-ko erock)c-i- MPLA___tcd oti9‘‘cohctS - 10(‘-)S 4/-16:3c-1 Se}:),14/).keel C>1 ond TALK-isinjedk:Tniv•bcier - COrtnaiirs40 ØtO9 tn-i-0 ( cire5 oho' covenens 9e P . cAcycsde • - s-k-abaltzortion of proott4- EFTA00266827 4 , Cosry-&-c ert-tycc4(on - cito)(ncrie, - calker-) seaceed and ,yt1y..Fts1n convet:skin - xnne‘c;kryks - brecisi or - d Irec-I )?yetio Ink° (cod,/ - nc\-i-or0( produ'els - more research rrecked . MerixecA - Skeds atsoich'S - Eyonii-± I-1-empb I t ta ieer-stens too - Rechtch Seavaeeok epcfrocl- lenS 4-o consfric--\ blooc.) in 4-,(c»..) ar-Nare3 - repoir (xAtelt5 er onci speoff -W-ikdrentr Cad . tAcb cck1 C.A. 1-YeAkC, - Sect v\)eect exk rack‘On - ‘1 \r‘kr-in‘et3 car sk‘n - SArek ch mar - fc)44.-9- 5\ctr) ok...cyrrerl-I CS ‘n\) 0‘ (.3 Mr‘ner+Cr il Bo‘‘c\‘, Mcgench - Seckv..)ecd krock on aler-:f', cs-rsk:.‘ ricairt orti - ce ‘reol Sjoiv\rea es,si rests4on+ e(ct,10±). ow-Nck ry-loc-Xer exickyyrie nsokkl-t en SeaLx)eted consorn on .4br- Inornon and Cfroiricti consort( k Cr) Neu-trod(se ( ° al t ne - re --Naircin ner-eked En.Jvconr-rerr\-Q1 - )nayskr CA\ v 5 e Orel Gp Ica-bons - B‘ of°cis Æcr mock)!rer•I ecluiren+ (CS el irym €t-nrn rorhs crintSpherCi ote-ww-u -)meni-cil . 4/ Cornb\nect v.)\-sr1n SoM vcier 4\1-brothoo S\ifsAern al\ enk reck- us,aii\ c_onsurnp}t on QT Indus-Frio( 0W, co clean d(Yolci (i.)crler _Fr horrors ConS0rfri-ten- enviru-~4O1 Korter v\b‘s-4:fe 5010-f on . EFTA00266828 - CNViRO T-4fAer\MP)L - SI NTEF PokkAakco1 Sc_\en-lkAs-k-- I No.)s -v-R-1 - i i,30 03-\--kke u - Tecknr-c‘ 031 t•aeť W91ain - I rn0Qcx\ --‘cůS Ino\OS-VC1 - En \I von rrtnkcA Po\t-k\cck1 I ryke.frO,CA• ken OOS• - 1C-rxarlIeCkS Re-S-O4rdn \oca Les - C' row sice4-(ane @ V3c.\ ICAďle • nO Zfoo\ \ Sct-Av e-Tial es-lirOC-41C-TO - c.e\\ %en q-00‘0 A‘TicyfloOn - IAL)nelosi C_C-tk \ktil OCirrn inks-leit vorc-k - Rese ťc_An Bink ť\S - (3triov.an seov.)sej e_yetťcel- ton icenarsicr) e \C`CAI IndOSAť la I 6/Vi VCrrnEnfQ PrOjed . ,e-ckkh)e-ec) c..."-1-kťociťkc-o k..)c-onot-kc, - CcrkQexs\00 r roakc cA ooAkcok t ons - (neol lc k no) c.Apxcle ccat ncy . C-P‘`c- Ck3c) s'°-O") , mi o\\J kn,c e>cc_.CSS‘ve neiL)c05 prodOced 101 baciearka I \ nAtc--4 kon - akv nAc_sY‘ c.c.s -rovirk - eccciuc-k ton coose J ske\N* 4 rfloccDS f‚ re.)0Řt)C-kkOn Reoscn cou ireac\i P)s o nixie( l'ere Iťeecklíčin etlerat -rerk CaYbInnZi kŇi+in reS0RS to 'T.( 4Cif•inkfe . RocAervok c\ts\-kc fibrOSIS Oanbircot v\3I-+h In 4Vr. body -ftor 03 Truces 1T1 I t te SUbStince. s+oync(n oc+ oLS - tee- ofd-) di scoAn B‘offernbraitS f rckncák e .)cos\ cf ,s - a Poď5 - ekk.)CoS G\ - RekeszkseS Cite9O «escočch sstrock ores - fee:_t_vrch pc:Act-that Qf braincy boctrs o and EFTA00266829 enocisi --lo ex4rcte+ 4)-cer book/ Or- ates-it-0\i (-Ks s-1-roc-fore • Ccmbine eed e, rc }tom pal -socciaDri, cell (rnrinc6\1 c-k Ice\ c..c 102,c4e,4-1q _Fcr ex-iv-cc-hoe) or des-Frock tor) - coin no+ or Iced in cet(s • Sockkr ec) rOCA tCO - (fit 1 c_c,,C/ o l 1r1 C-CA COY S ec c-tcOS - foOo/ Go I ()Ur - GoSro -tC._ xf-3) _robr c cr poc C9rods C-cA`Akc)° °()\ cb3r°9cri 'n 139 711(1-‘ Co \ cx.)Y-s . EFTA00266830 CONFIDENTIAL 3 C INNOVATIONS - 2019 \,1 EXECUTIVE SUMMARY - PROPOSAL - COMMERCIAL - MEDICAL - COSMETIC APPLICATIONS SEAWEED DISCOVERY PROJECT Concepts : Iodine : Seaweed extraction process - Engineered to be used in medical patients for medical Imaging - Administration, intravenous, injection - to be extracted by the body, normal bodily functions and engineered not to be absorbed by the body. Medical Sterilization : Seaweed extraction - Conversion into alcohol - swabs for the body -sterilization of patients, equipment or any other medical procedure that requires sterilization. Alginate : Conversion into gel - Stabilize direct administration involving Human Cell Direct Administration Project - Engineered to protect surrounding cells - Seaweed extraction of alginate Red Algal : Polysaccharides - Seaweed extraction - Cell immobilisation - Human Cell Direct Administration Project Cosmetic Applications / Developments : Body creams, facial creams, skin products - Anti wrinkle - Anti aging products - Natural source - Extraction - Seaweed and jellyfish - Combination - Marine biology - Polypherals, Lipids, Collagen,UV Protection / fish extract, anti oxidants, Peptides, skin collagen production. Research development, Not to be combined with oil based products that repel upon the skin resisting absorption of necessary ingredients to radiate and hydrate the skin - research needed into base product. Medical Applications : Bums - Extract seaweed and jellyfish - Collagen / water - combination - conversion into gel patches and coverings - Alginate - gel - stabilisation of product - adherent Cosmetic : Extraction - Alginate - Collagen from seaweed and jellyfish conversion - Implants - Breast or other forms of implants - Direct injection into the body - Natural products - More research needed. Medical : Bleeding Disorders - Example, Hemophilia, Hypertension - Research needed into Alginate / gel - Seaweed extractions to constrict blood flow in arteries - repair palettes and or offer support by thickening the blood. Medical Cosmetic : Seaweed extraction - whitening of the skin to be used on stretch marks - scarring - skin deformities involving pigmentation Seaweed Consumption : For human and animal consumption - Neutralise iodine - Research needed. Environmental : Industrial use and applications - Bio-fuels for machinery, equipment, EFTA00266831 CONFIDENTIAL d Ja INNOVATIONS - 2019 EXECUTIVE SUMMARY - MEDICAL RESEARCH DEVELOPMENT MENTAL ILLNESS / HEALTH - HORMONAL IMBALANCE DISORDER THEORY - EXCESSIVE - DEFICIENCY - ADRENAL GLANDS Hormonal Imbalance Disorder concerning mental illness / health - Physiological reaction / response to trauma or excessive stress - source - Adrenal gland disorder Adrenal Gland - Over stimulated releasing excessive Adrenal Gland — hormones into the system to the Thyroid - Physiological reaction to trauma or excessive stress Thyroid Gland - Becomes over stimulated - excessive Thyroid Gland _ horMones from Adrenal Gland causing disorder, in turn releases excessive hormone into the system to Pituitary Gland Pituitary Gland - Becomes over stimulated, excessive Pituitary Gland — hormones from Thyroid gland - causes disorder - releases too much hormones into the system connecting to Hypothalamie - Pituitary - Adrenal Axis Hypothalamie - Pituitary - Adrenal Axis - Scrambling Hypothalamie -Pituitary - - messages to the brain through excessive hormone Adrenal Axis release from conjoining glands causing disorder to occur Brain - Hippocampus - Disorder from Hypothalamie - Brain - Hippocampus - Pituitary - Adrenal Axis - scrambling messages - release of excessive hormones into the system to all glands resulting in Advanced Hormone Imbalance Disorder - Advance Mental illness / health Serotonin - Blocks, stops or alters production of Serotonin _ Serotonin to be released into the system - low levels - result of Hormonal Imbalance Disorder EFTA00266832 - ax9 \--keg)bNRcTTEN, POR- t 5 03 ne s 5 Cbnc:FIS t)Eco07 lc) tvk t v.) RI tLICI 14/-2'31 K1C4 FiCref SY 51ENIS t<i ccRk AL R.Cfri b6 fROT CACt)ERNIMENil CARetCX - ClQ,‘‘) • =.c-c n2 rrp led firr plier ncerri- eckvakc: Link \e-)e-s" '41 ri9c7s (CH 5Nr1)EN t...NwERN-r/ ---- 1 t ft175-1 4/ cilke-ci On Ct c cvniCkar uni 016 . G &1 4/76RN M ENT FUNMaTh EFTA00266833 VINcEMT- t5c5CoNle-r0ssEISC5ION CO•51-t 1.) tir-NC-A-Orrtctv c9O19 -act/. • I A 10{rnu\c, )-peuea V, -nee t..),e 04 FY CCO -h \je S~iwlr (.4 fl 1 3 O , --%CN\ Pc.coc5no ‘on Cr) • .- Pcir Sena\ Gateve-\e-cl - tI \6 EFTA00266834  fraLoSer4 Arkr___Nof-i ti tie . row _S es, a — T_on___cankoszktm __%00_4 0 oleic, 3 irt_ 4 0 Gast v - e & - irtc_e-v- v \s_... _ a-•___If_e_LIAr 4C:sk s M- oneslM attn.% c ov-Ackretk rick %tor% reku r tin) telt cmi-- -tsean c-gankoinatntektslar iesir lacteIspea -0-1e. ceceeti % c) k -r r-)c. Lava, - okels corti_takerk-d---MS-5--CanlatallaCaNaln--_ psi Tifinn t Ofl rorif--•• new.% S - -----= Tfra A Ion 43 V-az..\e i nc-L a ect ta swIrect 4 ekb tr• 04 ..., Ceektl-L. otrcLak____aaing frcc.e.eA__cxnck__ols.nate _ oreed ppe- -kink •ii, ct\e-ae1 , t - , . 7 \r-ax \ net tamed arc ) 0 t kr% Are --J --% ite.e.1 tort C4c:),uctunAnces.. - _anc2e_e_csike - IThe c ire aces dr OCkarrscal e% tetra Oroks•-e crec>4e an ordeses+emnattnal sic Viva tJtkr1 %SicLC _S 1;4 tiStet• 4'e p 14/11K1 -----t.tonakAikelLacti_enroarricctisa__ t ✓cu JkW v geit‘leS, or aloe- 4p vi)Qtrie Ve terfead co 1,:e7tint! wants Iro kt naQthea I4e_SkyrAKOPIN eAtC1r1 c-411%.)-k errta e 0kt:t ilted Cle 4 CA Cac • -AVe ACe-C31-4VN I %St.'" SI) !S conk - porn I r azor\ ton - uk-) A l tme se eeJe s y - tn.ta‘c ‘1._ eke-4-0k / cito C cora '1541 4 - Irr)o,v14/ .04S. trtekodea 1efrvJ EFTA00266835 NS-Mu-CD ON A COMPUTER aoc 7 / 11 /2016 Jacqueline Pearce Private and Confidential Australian Pharmaceutical Company Airborne Germs - Cross Contamination - Airborne Contaminates - Colds - Influenza - Associated airborne contaminates, as an example 'Dints of Interest : Target Market • Transport Services • Bus services • Airline services • Train services • Tram services • Work place environments - Office areas • Doctor's surgery's - Waiting rooms - Consultation rooms • Accommodation services • Food preparation services - Kitchen staff • Dental Clinics - Consultation rooms - Office areas - Waiting rooms • Education Departments and services - Class rooms - Office areas • Medical services - Establishments - Surgery - Office areas - Hospitals • Business Class - VIP's - Prominent positions - Office areas - Personal residence - First class travel services and areas Advantages - Increase - Decrease • Decrease cross contamination of germs - Through mouth, nose, touch of objects or other persons • Increase in work related capacity and productivity-Work place Environment • Decrease cross contamination within medical establishments, Hospitals, dental Clinics - Golden staff, for example - Mouth sores - Colds - Influenza - Increasing productivity and capacity within the medical establishments work environment, employee's, patients • Decrease cross contamination in relation to travel services and accommodation services within the cliental and employee's • Increasing productivity in educational environments • Eliminates cross contamination within food preparation environments and all above mentioned services - Public and personal • Provides special services for VIP'S, Professional positions - Prominent positions - First class travel services - Eliminates cross contamination - Increases productivity of the individual, work place environments, employee's • Increases and reduces costs of sterilization services - Safety of instruments and equipment exposed and used within the Medical establishments including Doctor's surgery's, Hospitals, Dental Clinics • Decreasing the use of prescribed antibiotics - Immune System creating other symptoms to occur, including the multiplying effects of super bugs associated with influenza and other bacterial diseases EFTA00266836 CONFIDENTIAL - JC INNOVATIONS - 2019 EXECUTIVE SUMMARY - MEDICAL RESEARCH PROJECT Designed 2016 DECONTAMINATION PROJECT TO PREVENT MICROBIAL INFECTIONS Airborne germs - Cross Contamination - Airborne Contaminates - Colds - Influenza Associated airborne contaminates Formula developed and expelled through the use of air conditioner units within these specific establishments and travel services eliminating the threat and cause of cross contamination, decreasing work related capacity and productivity within the individuals, stopping the spread of infections from country to country through airline services and including physicians, medical, dental clinics or employee's of these establishments. Eliminating the threat of cross contamination, lawsuits involved in medical issues, food establishments, airline services and public vehicle carrier services. Purifying the air in close proximity to the individual, areas of close proximity which include carrier services of public transport and airline services, medical establishments, waiting rooms, dental clinics and instruments used in such practices. Targeting untreatable symptoms unsuitable for antibiotic prescribed medications, which include Influenza, colds and other airborne cross contaminates. SPECIFICATIONS - TARGET MARKET • Transport services • Bus services • Airline services • Train services • Tram services • Workplace environments - Office areas • Doctors surgery's - Waiting rooms - Consultation rooms • Accommodation services - Hotels - Motels • Food preparation services - Kitchens - Kitchen staff • Dental Clinics - Consultation rooms - Office areas - Waiting rooms • Education Departments and services - Class rooms - Office areas • Medical services / Establishments - Surgery rooms - Wards - Office areas - Hospitals • Business class - VIPS - Prominent positions - office areas - Personal residence - First class travel services and areas LICENCES AND LEGAL REQUIREMENTS Research required for government or medical approval TRADING RECOMMENDATIONS Research required and under subject of licences and legal requirements ADVANTAGES - INCREASE - DECREASE • Decrease cross contamination of germs through mouth, nose, touch of objects or other persons • Increase in work related capacity and productivity - Work place environment • Decrease cross contamination within medical establishments, Hospitals, Dental EFTA00266837 C‘Per"?C k e Defoe r..)-itn4 . • '-iVCAJCP-Or soric* MM 13u5 1 NE 5 S LOGO c cas5v-\ Nme-s lekb-\ r o4c on-6'cri Cr 5 fr,Se -Cy i son5oe ant- ,fa, ENN \iftr it N,307\ er r e 0.) S FIANO v.mt--crem - PoRT ewe tw_-_-)recce (A-NJ cc INTER PC)---nSenicits1 - On)t.) ERs p scOSS (ON\ EFTA00266838 ()OA k S S)IC k Val c14/ .AarrkS P rCt ert ‘C Ckt (-Acme rcunibti - Worsk -I earnr '.A.-.-4-vteeS tadLp CVO 5.xtecAS 5,), 1 4/) t\foo le>6 fe,,A \es(4 vncrk-‘ve 4/r 4 ric 1 °Amok Su c c o kerb S HANC) \MR ITTEN ti<C;"Tesit...C.O ON f3) COMPUTCR . UN' Velk5 IT/ 'S CAo4e.m.rterNn 'Fuca oet) EFTA00266839 J_NfoRtiED BY Z-OSePd cassoR IN HIS Posse/55'0N aOpo noccitl ONiverri altchrntiCY bEPPRT-Parr CONFIDENTIAL - JC INNOVATIONS DESIGNED APRIL 2020 SOCIAL MEDIA CHILDREN'S SECURITY PROGRAM - PAEDOPHILIA TARGETING EXECUTIVE SUMMARY - DIGITAL CONTACT - SOCIAL MEDIA WEBSITES The Social Media Security Program is a computer program designed as a patch to apply to a Social Media Network/Website in order to protect children from predatory actions of a paedophile, including grooming, conditioning, digital contact or personal contact with the individual / child under a specific age or within a specific age group. The program will include a data base of registered paedophiles and aliases known to have been used in previous legal cases and of whom have been convicted of sexual offences, which include indecent exposure to children, grooming, possession of explicit sexual material, physical sexual offences or any other forms of illegal activity of a sexual nature involving children. The program is designed to recognise any forms of unusual / suspicious activity involving digital contact with children, which include data recording and notification to the website and authorities of account activation and personal details of the predator / suspect once any unusual activity has been detected. Unusual activity will include the detection of specific words used in grooming, conditioning, unusual constant / persistent contact by an adult connected to the children's accounts, messaging inboxes, invitation and cohesion for personal contact, requested photographs of the child, personal information involving residential details, age, personal description, friends information, personal movements involving sports activities, locations or any other forms of locations and at specific times, family personal information involving employment, residential, relationship status, movements of location and or times, will be automatically monitored by the program upon account activation of the child within a specific age group. The program is designed to link to all legal services involving, licence registration, car registrations, Centrelink registrations or any other forms of legal registrations that require name, address, age and legal prosecutions and are linked to the children's account through personal digital contact, friend requests, messaging or any other forms of contact with that child within that specific age group, including friends, family members or strangers. The specific age group of the children that the program will monitor and protect with the specific forms of contact upon the social media networks/websites will be that of 0 -18 years of age. SPECIFICATIONS The Social Media Security Program is designed as a patch to be an inclusion to already established or under development and operational Social Media Websites that consists of the inclusion of under age, 18 years and under children and teenagers. The patch is designed as an upgrade/inclusion of the established system to be installed by their contracted IT Specialist or Website Developer to protect the under age children from predatory activity and reduce or eliminate any form of litigation or claim against their website for this activity. Incorporated Features - Monitored Activity - Digital Personal Contact • Grooming • Conditioning • Adult contact - Family members, Friends, Friend requests, Strangers / Unknown to the child • Criminal Data Base of convicted paedophiles and sex offenders involving children under the age of 18 years old - Indecent exposure, grooming, possession of explicit material, physical sexual offences, kidnapping or any other forms of illegal conduct • Known alias's used - Convicted Criminal Data Base • Monitor, recognise and detection of unusual/suspicious activity - Specific words used in grooming and conditioning, Unusual/persistent/constant contact by an adult, Invitation or cohesion for personal contact, Requested photographic material, Personal information • involving sports activities, locations or any other forms of location, Personal movements involving sports activities, personal activities, school activities and times/specific times, Family information involving employment, residential addresses, relationship status, movements/locations and or times. EFTA00266840 • Website proprietor notification of detected activity - Alerting the website of the activity • Monitoring of adult account personal information connected to child's account • Linked to legal services / authorities involving conviction - Reporting activity detected, licence registration, car registration, Centrelink registration or any other forms of registration that require personal details such as name, address, age and personal details for verification and relationship to child • Monitors friend requests and personal messaging or any forms of personal digital contact with the child from an adult • Social Media Security Program is designed to be updated annually in accordance with updated information of Criminal Data Base, information collected and known of illegal activity and behaviour of predatory behaviour upon websites involving children, Updated incorporated features of the program TARGET MARKET AND AGE GROUP • Children under the age of 18 years old with a registered profile on any Social Media Website - e.g, Facebook • Parents who are unable to monitor or control their children's usage and activity on Social Media Websites due to the lack of education, work restrictions, unruly child or any other restrictions that may impose their control and supervision • Social Media Website Proprietors of any Social Media Website which also may include dating sites that may have under age children registering on their sites • Any forms of digital personal contact which include Twitter, Blogs, Facebook ect LICENCES AND REQUIREMENTS • Registered with Criminal Conduct authorities - Criminal Data Base and reporting of activity • Registered with departments of personal information data base and registrations - Verification of personal details or change of details • (ASIC) Australian Criminal Intelligence Commission - eSafety Commissioner ( Cyber crime and Identity Security) - involving the monitoring and collection of personal details/ information involving registered profiles and reporting of Cyber Crime • Business registration • Patent and Copyright registration TRADING RECOMMENDATIONS • Online sales to proprietors of Social Media Websites • IT Specialists • Computer Software Developers - Website Developers and Design COMPETITION - NICHE MARKET - WORLDWIDE Due to the design and features of the Social Media Security Program in the initial stages of sales the market is open to no competition being the first design of it's type on the market. The viability of this program is of a high ranking and long term viability status due to the nature of the design, obtained Patent and Copyright licensed registration and annual updated features. BENEFITS • Parent security for their children's safety of digital personal contact without supervision • Reduces predatory activity of digital contact and proceeding to personal contact and harm of the child • Reduces avenues of predatory behaviour and activity that place the child in danger • Exposes predatory behaviour and paedophiles that hide under the veil and detection of a digital mask • Reduces the danger of a child revealing their personal details to an unknown or known adult that may be predatory or grooming/conditioning the child for such stated activity and sexual assault, kidnapping for sexual assault or human trafficking EFTA00266841  JC INNOVATIONS AUSTRALIA MUTUAL NON DISCLOSURE AGREEMENT The Undersigned: 1. JC INNOVATIONS a company under the laws of Australia within the registered office of Australian Business Register, Penrith, NSW, 2740, hereby duly represented by Jacqueline Pearce, its Director / Owner. 2 Joseph Cassar an interested party / investor agree to abide by the Australian Intellectual Property Laws upon the disclosure of the business concepts and developments and remain the property of JC INNOVATIONS. This Mutual Agreement stipulates that either party may be either or both the "Disclosing Party" and / or the "Receiving Party" with information exchanged between the two parties in the course of discussions with the purpose as outlined in Exhibit A and B of this Agreement. TERMS AND CONDITIONS Both parties agree as follows; 1. OBLIGATION OF CONFIDENTIALITY Each recipient will; 1.1. The business concepts and developments containing Confidential Information will be treated as confidential and will not be disclosed to a third party unless discussed and negotiated with JC INNOVATIONS and is limited to; 1.1.2. Representatives of the recipient who have a need to know and who are bound by an obligation not to disclose Confidential Information otherwise than in accordance with this Agreement. 1.1.3. To consultants, professional advisors or associates of the recipient to whom the Confidential Information is disclosed for the purpose outlined in Exhibit A and B and who owe a duty of Confidentiality to the recipient and are aware of the recipients obligations under this agreement. 1.1.4. The disclosure of the business concepts and developments are subjected to Intellectual Property Law, Australia and remain the property of JC INNOVATIONS unless negotiated and/or discussed with the recipient or interested party involved, pending further legally binding Agreements, Patents, Copyrights necessary or discussed in the developments between both parties. 1.1.5. It is prohibited to copy, share, record or alter the Confidential Information disclosed and is subject to Intellectual Property Law, Australia. 1.1.6. Keep the Confidential Information secure. 1.1.7. On the written request of the disclosure, cease to disclose, copy or use any Confidential Information, or allow it to be disclosed, copied or used. 1.1.8 Cooperate with the disclosure in any reasonable action which it may take to protect the Confidential Information and ensure that all third parties recognised as representatives, professional advisors, associates or to whom the Confidential EFTA00266842  Information has been disclosed for any purpose are obligated to this cooperation Agreement in this instance. 1.1.9. There are no exceptions to this Agreement and the recipient would be subject to a Breech of Obligations under this Agreement of which Intellectual Property Laws, Australia will apply. 2. EXCLUSIONS 2.1. The obligations in Clause 1 do not apply to Confidential Information which; 2.2.1. Was in the public domain at or after the time it was disclosed by the disclosing party to the receiving party, other than through a Breech of this Agreement. 2.2.2. The recipient can prove it was in its lawful possession prior to disclosure by the disclosure and which was not acquired directly or indirectly from the disclosure or a third party under an Obligation of Confidentiality. 2.2.3. Required to be disclosed by law or applicable legal processes, provided that the recipient; To the extent permitted by law or applicable legal processes, immediately notifies the disclosure of any such request where possible before, or as soon as practicable after, making the disclosure. 3. RETURN OR DESTRUCTION Immediately upon termination or expiry of this Agreement, the decision by either party not to enter into a Business or Development Agreement contemplated within the disclosure of the Confidential Information, a request by the disclosure at any time, the recipient by the disclosure will; 3.2.1 Promptly return to the disclosure, or if directed by the disclosure destroy, all Confidential Information of the disclosure and all documents and other tangible materials containing any such Confidential Information, including disclosed information held by any third party recognised as representatives, professional advisors, associates or to whom Confidential Information has been disclosed. 3.2.2 The recipient will certify compliance with any directions of the disclosure's to destroy Confidential Information within 14 days of receipt of such direction. 4. RISK MANAGEMENT 4.2. Each party (the first party) will be liable to the other party for any act or omission of any third party to which the first party disclosed the Confidential Information, as if those acts or omissions were the first parties own. 4.3. Nothing in this Agreement is intended to grant any rights under any Patent, Trade 4.4. Secrets or Copyrights of either party to the other, nor shall this Agreement grant the receiving party any right in or to the Confidential Information of the disclosing party, except the limited right to review such Confidential Information solely in connection with the Business Purpose as described in Exhibit A and B. 4.5. The recipient agrees that the disclosure assumes no responsibility or liability for the recipients use of the Confidential Information, and that the disclosure gives no warranty that the Confidential Information will meet the recipients requirements as outlined in Exhibit A and B, Business Purpose or it will be sufficient or suitable for the recipients authorised purposes. 4.6. This Agreement may be modified in writing, executed only by authorised representatives of each party and approved only by the disclosure of the Confidential Information. 4.7. The disclosure is entitled to seek relief both at law and equity and remedies including (without limitation) injunctive relief and specific performance in the event of any Breech or anticipated Breech of this Agreement, without having to prove any actual damage. 4.8. This Agreement will be governed by the laws of Australia. Both parties agree that any dispute, controversy or claim arising out of or in connection with this Agreement, or EFTA00266843  Breech, Termination or Invalidity thereof, shall be settled by the relevant tribunal in Australia. 5. TERM 5.1 The effective commencement date of this Agreement will be the time stated